Keya Medical
PrivateLast Round
Series D
Dec 31, 2020
Total Funding Raised
$112M
Company Overview
Keya Medical is an international medical technology company founded in 2016 that develops and provides artificial intelligence-based software and devices for disease diagnosis and treatment. The company specializes in deep learning solutions for various medical fields including cardiology, neurology, and pulmonology. Its flagship product, DEEPVESSEL FFR, is a non-invasive software that uses deep learning on CCTA scans to perform a physiological assessment of coronary arteries, and has received regulatory clearance from the NMPA in China, CE Mark in Europe, and the FDA in the US. Headquartered in Beijing, the company also has offices in Seattle, Shanghai, and Shenzhen and collaborates with hundreds of hospitals worldwide. Keya Medical is venture-backed, having raised over $110 million by early 2021 through multiple funding rounds including a Series D.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keya Medical Comps
Public and private peers based on sector, stage, and business model.
Keya Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 31, 2020 | ||||
| Series C | Nov 12, 2020 | ||||
| Series B Extension | Aug 13, 2020 | ||||
| Series B | Feb 19, 2020 |
Keya Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series B, Series B Extension, Series C |
| INcapital Ventures | Series D |
| Yueyin Medical Fund | Series D |
| IDG Capital | Series B, Series C |
| Source Code Capital | Series C |
| Lingang Sc-innovation Investment | Series D |
| Shanghai Guofang FOF | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
Will be exhibiting at the RSNA 2025 conference.
- Jul 8, 2025
Expanding US offices to increase regional coverage.
Keya Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Keya Medical's valuation, stock price, and market status.
